Drupal.behaviors.print = function(context) {window.print();window.close();}>
Luminex Posts 30 Percent Q1 Revenue Growth
May 07, 2010
Luminex Posts 30 Percent Q1 Revenue Growth
Luminex reported growth across all of its segments, with particularly strong sales for its assays.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Luminex Discloses GenturaDx Loss of $19.8M in 2011, $18.5M in H1 2012
September 18, 2012 / GenomeWeb Daily News
Strong Consumables Growth Drives Luminex's Q4 Revenues up 8 Percent
February 8, 2011 / GenomeWeb Daily News
Luminex Leveraging Advanced Liquid Logic Alliance to Develop Field-based MDx/Immunoassay System
May 16, 2013 / PCR Insider
Despite Continued Genotyping Growth, Weak Expression Sales Force Affymetrix to Suspend Guidance
May 7, 2013 / BioArray News
Luminex in Alpha Stage for New MDx Platform; Ups R&D Spending to Prep for Market
May 2, 2013 / PCR Insider